Rocket Pharmaceuticals, Inc. Treasury Stock, Shares
Rocket Pharmaceuticals, Inc. (RCKT) had Treasury Stock, Shares of 2.57 thousand shares as of 2023-03-31, per its 10-Q filed 2023-05-05.
Discontinued › Notes
us-gaap:TreasuryStockShares · last filed 2023-05-05
- 2023-03-31: Treasury Stock, Shares 2.57K shares.
- 2022-12-31: Treasury Stock, Shares 2.57K shares.
- 2021-12-31: Treasury Stock, Shares 0.00 shares.
| Period end | Treasury Stock, Shares |
|---|---|
| 2023-03-31 | 2.57K shares 10-Q · filed 2023-05-05 |
| 2022-12-31 | 2.57K shares 10-Q · filed 2023-05-05 |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |